Esperion Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	92.45	144.76	82.25	124.78	208.89	304.96
Short-Term Investments	-	-	-	42.09	50.44	-
Cash & Short-Term Investments	92.45	144.76	82.25	166.86	259.33	304.96
Cash Growth	-36.12%	76.00%	-50.71%	-35.66%	-14.96%	51.89%
Receivables	118.98	80.14	48.49	33.73	22.93	12.39
Inventory	141.84	94.49	65.62	35.2	34.39	16.14
Prepaid Expenses	7.2	18.6	4.7	10.89	12.31	12.41
Total Current Assets	360.46	338	201.07	246.68	328.97	345.9
Property, Plant & Equipment	3.5	5.77	4.68	1.2	2.56	7.31
Other Intangible Assets	0.06	0.06	0.06	0.06	0.06	0.06
Other Long-Term Assets	-	-	-	-	50	-
Total Assets	364.02	343.82	205.8	247.94	381.59	353.26
Accounts Payable	77.51	51.65	31.72	23.04	17.56	51.98
Accrued Expenses	20.26	24.63	28.44	18.63	21.23	27.43
Current Portion of Long-Term Debt	149.69	102.16	34.83	24.76	11.3	5.39
Current Portion of Leases	2.38	2.74	1.55	0.38	1.39	2.59
Current Unearned Revenue	30.68	8.52	25.4	3.51	5.68	1.66
Other Current Liabilities	78.51	56.54	34.28	21.99	16.19	5.03
Total Current Liabilities	359.03	246.23	156.22	92.31	73.35	94.07
Long-Term Debt	448.15	483.74	501.55	478.74	504.02	350.58
Long-Term Leases	0.77	2.57	3.02	0.67	0.52	3.45
Long-Term Unearned Revenue	-	-	-	-	0.63	-
Other Long-Term Liabilities	7.44	-	-	-	-	1.29
Total Liabilities	815.38	732.54	660.79	571.72	578.53	449.39
Common Stock	0.21	0.2	0.12	0.08	0.06	0.03
Additional Paid-In Capital	1,289	1,267	1,149	1,071	964.4	797.66
Retained Earnings	-1,686	-1,601	-1,549	-1,340	-1,106	-838.82
Treasury Stock	-55	-55	-55	-55	-55	-55
Comprehensive Income & Other	-	-	-	-0	-0.03	-
Shareholders' Equity	-451.36	-388.72	-454.99	-323.78	-196.94	-96.13
Total Liabilities & Equity	364.02	343.82	205.8	247.94	381.59	353.26
Total Debt	600.99	591.21	540.95	504.55	517.24	362.01
Net Cash (Debt)	-508.54	-446.45	-458.7	-337.69	-257.9	-57.05
Net Cash Per Share	-2.57	-2.39	-4.45	-5.09	-8.92	-2.08
Filing Date Shares Outstanding	237.07	197.85	185.05	76.57	62.82	27.94
Total Common Shares Outstanding	205.43	195.85	118.21	74.57	60.88	25.92
Working Capital	1.43	91.77	44.84	154.38	255.62	251.83
Book Value Per Share	-2.20	-1.98	-3.85	-4.34	-3.23	-3.71
Tangible Book Value	-451.42	-388.78	-455.05	-323.83	-197	-96.19
Tangible Book Value Per Share	-2.20	-1.99	-3.85	-4.34	-3.24	-3.71
Machinery	-	0.86	0.86	1.45	1.45	1.45
Leasehold Improvements	-	0.19	0.19	0.3	0.3	0.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.